132 related articles for article (PubMed ID: 36062762)
81. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
[TBL] [Abstract][Full Text] [Related]
82. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
[TBL] [Abstract][Full Text] [Related]
83. Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.
Mo X; Wu X; Dong D; Guo B; Liang C; Luo X; Zhang B; Zhang L; Dong Y; Lian Z; Liu J; Pei S; Huang W; Ouyang F; Tian J; Zhang S
Eur Radiol; 2020 Feb; 30(2):833-843. PubMed ID: 31673835
[TBL] [Abstract][Full Text] [Related]
84. The Concentration of Iodine in Perigastric Adipose Tissue: A Novel Index for the Assessment of Serosal Invasion in Patients with Gastric Cancer after Neoadjuvant Chemotherapy.
Yang L; Li Y; Shi GF; Zhou T; Tan BB
Digestion; 2018; 98(2):87-94. PubMed ID: 29698943
[TBL] [Abstract][Full Text] [Related]
85. Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study.
Ding P; Guo H; Sun C; Yang P; Kim NH; Tian Y; Liu Y; Liu P; Li Y; Zhao Q
BMC Gastroenterol; 2022 Mar; 22(1):121. PubMed ID: 35287591
[TBL] [Abstract][Full Text] [Related]
86. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
87. Development and Validation of a Radiomics Model Based on
Xue B; Jiang J; Chen L; Wu S; Zheng X; Zheng X; Tang K
Front Oncol; 2021; 11():740111. PubMed ID: 34765549
[TBL] [Abstract][Full Text] [Related]
88. ABVS-Based Radiomics for Early Predicting the Efficacy of Neoadjuvant Chemotherapy in Patients with Breast Cancers.
Jiang W; Deng X; Zhu T; Fang J; Li J
Breast Cancer (Dove Med Press); 2023; 15():625-636. PubMed ID: 37600669
[TBL] [Abstract][Full Text] [Related]
89. Diagnostic accuracy of radiomics-based machine learning for neoadjuvant chemotherapy response and survival prediction in gastric cancer patients: A systematic review and meta-analysis.
Adili D; Mohetaer A; Zhang W
Eur J Radiol; 2024 Apr; 173():111249. PubMed ID: 38382422
[TBL] [Abstract][Full Text] [Related]
90. Radiomic Analysis of Pulmonary Nodules for Distinguishing Malignancy From Benignancy: The Value of Using Iodine Maps From Dual-Energy Computed Tomography.
Zhong Y; Xu H; Zhang W; Li H; Yu TF; Yuan M
J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):878-883. PubMed ID: 35830384
[TBL] [Abstract][Full Text] [Related]
91. CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer.
Wan S; Zhou T; Che R; Li Y; Peng J; Wu Y; Gu S; Cheng J; Hua X
J Ovarian Res; 2023 Jan; 16(1):1. PubMed ID: 36597144
[TBL] [Abstract][Full Text] [Related]
92. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
93. Extraction parameter optimized radiomics for neoadjuvant chemotherapy response prognosis in advanced nasopharyngeal carcinoma.
Wang Y; Li C; Yin G; Wang J; Li J; Wang P; Bian J
Clin Transl Radiat Oncol; 2022 Mar; 33():37-44. PubMed ID: 35024463
[TBL] [Abstract][Full Text] [Related]
94. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
[TBL] [Abstract][Full Text] [Related]
95. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
96.
Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
Front Oncol; 2022; 12():911168. PubMed ID: 36003788
[TBL] [Abstract][Full Text] [Related]
97. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.
Sugai Y; Kadoya N; Tanaka S; Tanabe S; Umeda M; Yamamoto T; Takeda K; Dobashi S; Ohashi H; Takeda K; Jingu K
Radiat Oncol; 2021 Apr; 16(1):80. PubMed ID: 33931085
[TBL] [Abstract][Full Text] [Related]
98. Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy.
Zhang L; Ge Y; Gao Q; Zhao F; Cheng T; Li H; Xia Y
Front Oncol; 2021; 11():758921. PubMed ID: 34868973
[TBL] [Abstract][Full Text] [Related]
99. Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers.
Wang Z; Lin F; Ma H; Shi Y; Dong J; Yang P; Zhang K; Guo N; Zhang R; Cui J; Duan S; Mao N; Xie H
Front Oncol; 2021; 11():605230. PubMed ID: 33692950
[TBL] [Abstract][Full Text] [Related]
100. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
